With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing ...
GLAXOSMITHKLINE (GSK) has confirmed that its manufacturing operations will cease next year as its current contract with a ...
GSK said the vast majority of the products will be for export to global markets, adding that the investment builds on the company’s existing network of nine UK manufacturing sites, employing ...
The site at Ulverston currently belongs to GlaxoSmithKline (GSK), which ... it wanted to establish the area as a "nationally-advanced manufacturing location". The proposals include "flexible ...
In 2022, GSK’s 12 manufacturing sites in eight countries produced and delivered more than 500 million vaccine doses—one and a half million vaccine doses daily. Each year, about 40% of the ...
"GSK reports positive interim data from mRNA influenza vaccine trial" was originally created and published by Clinical Trials ...
GSK was able to avert industrial action at some ... The Unite union, representing around 160 workers at the Montrose site, said the offer constitutes a “substantial real terms pay cut” given ...
Pharmaceutical company Glaxo Smith Kline has been described as a long-standing 'integral part of the Ulverston community' as local people express sadness at its impending closure.
Consider this real-life example: A single mom with two small children is a shift supervisor at a manufacturing plant ... Foxconn, GSK, LG Electronics, Mondelez, Procter & Gamble, Siemens, and ...
The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...
Working out of 12 manufacturing sites, the company distributed 767 million vaccine doses across more than 160 countries in 2021. More than ten million people received one of GSK’s meningococcal ...
GSK assumed full control for the development, manufacturing and commercialization of influenza vaccines through new licensing agreement TÜBINGEN, Germany/BOSTON, USA – September 12, 2024 – CureVac N.V ...